» Subscribe Today!
The Power of Information
Home
The Ledger - EST. 1978 - Nashville Edition
X
Skip Navigation LinksHome > Name & Property Search

Name & Property Search

Search results for 'Moderna' | Search again
DeSoto Public Records:0
Shelby Public Records:0
Editorial:100
West Tennessee:0
Middle Tennessee:6
East Tennessee:0
Other:0

You must be a subscriber to see the full results of your search.

Please log in or subscribe below if you are not already a subscriber.

TNLedger Knoxville Edition subscribers get full access to more than 13 million names and addresses along with powerful search and download features. Get the business leads you need with powerful searches of public records and notices. Download listings into your spreadsheet or database.

Learn more about our services | Search again


Editorial Results (free)

1. FDA panel backs Pfizer's low-dose COVID-19 vaccine for kids -

WASHINGTON (AP) — The U.S. moved a step closer to expanding COVID-19 vaccinations for millions more children as government advisers on Tuesday endorsed kid-size doses of Pfizer's shots for 5- to 11-year-olds.

2. FDA advisers review Pfizer's COVID-19 vaccine for kids -

WASHINGTON (AP) — Kid-size doses of Pfizer's COVID-19 vaccine may be getting closer as government advisers on Tuesday began deliberating whether there's enough evidence that the shots are safe and effective for 5- to 11-year-olds.

3. Wall Street sets more records as earnings season gears up -

NEW YORK (AP) — Wall Street ticked further into record heights on Monday, as a better-than-expected profit reporting season gets into higher gear.

The S&P 500 rose 21.58 points, or 0.5%, to 4,566.48 and surpassed its last record set on Thursday. The Dow Jones Industrial Average also reached an all-time high after adding 64.13, or 0.2%, to 35,741.15. The Nasdaq composite picked up 136.51, or 0.9%, to 15,226.71..

4. US details new international COVID-19 travel requirements -

WASHINGTON (AP) — Children under 18 and people from dozens of countries with a shortage of vaccines will be exempt from new rules that will require most travelers to the United States be vaccinated against COVID-19, the Biden administration announced Monday.

5. Moderna says its low-dose COVID shot works for kids 6 to 11 -

Moderna said Monday that a low dose of its COVID-19 vaccine is safe and appears to work in 6- to 11-year-olds, as the manufacturer moves toward expanding shots to children.

Competitor Pfizer's kid-sized vaccine doses are closer to widespread use, undergoing evaluation by the Food and Drug Administration for nearly the same age group — starting at age 5. Its vaccine already is authorized for anyone 12 or older.

6. EXPLAINER: Is it time to get a COVID-19 booster? Which one? -

Millions more Americans just became eligible for COVID-19 boosters, but figuring out who's eligible and when can be confusing. And adding to the challenge is that this time around, people can choose a different brand of vaccine for that extra dose.

7. COVID vaccine: CDC expands booster rollout, OKs mixing shots -

WASHINGTON (AP) — Millions more Americans can get a COVID-19 booster and choose a different company's vaccine for that next shot, federal health officials said Thursday.

Certain people who received Pfizer vaccinations months ago already are eligible for a booster and now the Centers for Disease Control and Prevention says specific Moderna and Johnson & Johnson recipients qualify, too. And in a bigger change, the agency is allowing the flexibility of "mixing and matching" that extra dose regardless of which type people received first.

8. AP FACT CHECK: Biden overstates his record on COVID vaccine -

WASHINGTON (AP) — President Joe Biden botched the numbers behind the COVID-19 vaccine rollout Thursday as he stretched to take all the credit for the surge of shots once he was in office.

A look at his remarks during a CNN town hall event:

9. COVID-19 vaccine: CDC panel discusses booster rollout -

WASHINGTON (AP) — Influential government advisers are deciding Thursday how best to expand the nation's COVID-19 booster campaign, including whether and when it's OK to "mix and match" brands for the extra dose.

10. FDA OKs mixing COVID vaccines; backs Moderna, J&J boosters -

WASHINGTON (AP) — U.S. regulators on Wednesday signed off on extending COVID-19 boosters to Americans who got the Moderna or Johnson & Johnson vaccine and said anyone eligible for an extra dose can get a brand different from the one they received initially.

11. US marks 200M COVID-19 shots shared with world -

WASHINGTON (AP) — The U.S. on Thursday donated its 200 millionth COVID-19 shot to help vaccinate the rest of the world, the White House announced. The Biden administration aims to lead a global vaccination campaign even as it rolls out boosters for domestic use, which critics say diverts doses from those who are in greater need around the world.

12. FDA OKs mixing COVID vaccines; backs Moderna, J&J boosters -

WASHINGTON (AP) — U.S. regulators on Wednesday signed off on extending COVID-19 boosters to Americans who got the Moderna or Johnson & Johnson vaccine and said anyone eligible for an extra dose can get a brand different from the one they received initially.

13. White House details plans to vaccinate 28M children age 5-11 -

WASHINGTON (AP) — Children ages 5 to 11 will soon be able to get a COVID-19 shot at their pediatrician's office, local pharmacy and potentially even their school, the White House said Wednesday as it detailed plans for the expected authorization of the Pfizer shot for elementary school youngsters in a matter of weeks.

14. Will vaccine hesitancy extend to little arms? -

Nashville dad Pierce Sandwith jumped at the chance to have his 2-year-old daughter vaccinated against COVID-19 as part of a clinical trial at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

15. White House details plans to vaccinate 28M children age 5-11 -

WASHINGTON (AP) — Children ages 5 to 11 will soon be able to get a COVID-19 shot at their pediatrician's office, local pharmacy and potentially even their school, the White House said Wednesday as it detailed plans for the expected authorization of the Pfizer shot for elementary school youngsters in a matter of weeks.

16. US expected to authorize mix-and-match COVID booster shots -

WASHINGTON (AP) — Federal regulators are expected to authorize the mixing and matching of COVID-19 booster shots this week in an effort to provide flexibility for those seeking to maintain protection against the coronavirus.

17. J&J hikes 2021 profit forecast, COVID-19 vaccine sales grow -

Johnson & Johnson is raising its 2021 profit forecast again after growing sales of the cancer treatment Darzalex and other drugs pushed it past Wall Street's third-quarter earnings expectations.

The health care giant also said Tuesday that sales of its single-shot COVID-19 vaccine started to pick up in the quarter, nearly doubling what it brought in during the first half of the year.

18. FDA panel endorses booster shot for J&J COVID-19 vaccine -

WASHINGTON (AP) — U.S. health advisers endorsed a booster of Johnson & Johnson's COVID-19 vaccine Friday, citing growing worry that Americans who got the single-dose shot aren't as protected as those given two-dose brands.

19. FDA panel endorses lower-dose Moderna COVID shot for booster -

U.S. health advisers said Thursday that some Americans who received Moderna's COVID-19 vaccine at least six months ago should get a half-dose booster to rev up protection against the coronavirus.

The panel of outside advisers to the Food and Drug Administration voted unanimously to recommend a booster shot for seniors, as well as younger adults with other health problems, jobs or living situations that put them at increased risk from COVID-19.

20. FDA panel debates lower-dose Moderna COVID shots for booster -

U.S. health advisers are debating if millions of Americans who received Moderna vaccinations should get a booster shot -- this time, using half the original dose.

Already millions who got their initial Pfizer shots at least six months ago are getting a booster of that brand. Thursday, advisers to the Food and Drug Administration evaluated the evidence that Moderna boosters should be offered, too -- and on Friday, they'll tackle the same question for those who got Johnson & Johnson's vaccine.

21. FDA grapples with timing of booster for J&J COVID-19 vaccine -

WASHINGTON (AP) — The Food and Drug Administration is wrestling with whether and when to offer a booster of the single-shot Johnson & Johnson COVID-19 vaccine — at six months or as early as two months. And a new study raises the prospect that using a different vaccine might give a better boost.

22. Next on FDA's agenda: Booster shots of Moderna, J&J vaccines -

WASHINGTON (AP) — With many Americans who got Pfizer vaccinations already rolling up their sleeves for a booster shot, millions of others who received the Moderna or Johnson & Johnson vaccine wait anxiously to learn when it's their turn.

23. Finland joins other Nordic nations in curbing Moderna shots -

COPENHAGEN, Denmark (AP) — Finland has joined other Nordic countries in suspending or discouraging the use of Moderna's COVID-19 vaccine in certain age groups because of an increased risk of heart inflammation, a rare side effect associated with the shot.

24. New FDA chief can't come soon enough for beleaguered agency -

WASHINGTON (AP) — Straining under a pandemic workload and battered by a string of public controversies, one of the leading agencies in the government's fight against COVID-19 is finally on the verge of getting a new commissioner.

25. UK eases travel restrictions further by slashing 'red list' -

LONDON (AP) — The British government said Thursday that it is to relax travel rules further next week, a move that will open up many long-distance holiday destinations to travelers for the first time since the onset of the coronavirus pandemic a year and half ago.

26. Pentagon mandates COVID-19 vaccine for civilian workers -

WASHINGTON (AP) — All civilians who work for the Defense Department and the military services must be fully vaccinated for COVID-19 by Nov. 22, under new guidelines released Monday.

A memo signed by Deputy Defense Secretary Kathleen Hicks on Friday said the new mandate is in line with the presidential directive issued last month requiring federal agencies to implement vaccine requirements.

27. US unveils guidance for federal vaccine mandate, exemptions -

WASHINGTON (AP) — With just weeks remaining before federal workers must be vaccinated against COVID-19, the federal government on Monday outlined procedures for employees to request medical or religious exemptions from President Joe Biden's mandate.

28. J&J seeks US clearance for COVID-19 vaccine booster doses -

WASHINGTON (AP) — Johnson & Johnson asked the Food and Drug Administration on Tuesday to allow extra shots of its COVID-19 vaccine as the U.S. government moves toward expanding its booster campaign to millions more vaccinated Americans.

29. Am I fully vaccinated without a COVID-19 vaccine booster? -

Am I fully vaccinated without a COVID-19 vaccine booster? Yes, people who got a two-dose vaccine or the single-dose Johnson & Johnson shot are considered fully vaccinated — even without a booster.

30. Poll finds deep divide over Biden vaccine mandate -

A survey of Americans on President Joe Biden's plan to require most workers to get either vaccinated or regularly tested for COVID-19 finds a deep and familiar divide: Democrats are overwhelmingly for it, while most Republicans are against it.

31. Pfizer vaccine for kids may not be available until November -

WASHINGTON (AP) — Pfizer has submitted research to the U.S. Food and Drug Administration on the effectiveness of its COVID-19 vaccine in children but the shots may not be available until November.

The company said Tuesday it provided health regulators with data from a recent study of its vaccine in children 5 to 11 years old. Officials had said previously they would file an application with the FDA to authorize use in the coming weeks.

32. Biden gets COVID-19 booster shot after authorization -

WASHINGTON (AP) — President Joe Biden joked about his age Monday as he rolled up his sleeve for a COVID-19 booster shot, encouraging Americans to get vaccinated against the virus that has killed 688,000 in the U.S. and for those authorized to get their booster doses for more enduring protection.

33. US booster shots start, even as millions remain unprotected -

The U.S. launched a campaign to offer boosters of Pfizer's COVID-19 vaccine to millions of Americans on Friday even as federal health officials stressed the real problem remains getting first shots to the unvaccinated.

34. CDC endorses COVID booster for millions of older Americans -

The Centers for Disease Control and Prevention on Thursday endorsed booster shots for millions of older or otherwise vulnerable Americans, opening a major new phase in the U.S vaccination drive against COVID-19.

35. FDA backs Pfizer COVID-19 boosters for seniors, high-risk -

The U.S. moved a step closer Wednesday to offering booster doses of Pfizer's COVID-19 vaccine to senior citizens and others at high risk from the virus as the Food and Drug Administration signed off on the targeted use of extra shots.

36. Q&A: America's new COVID-19 rules for international travel -

WASHINGTON (AP) — The Biden administration is rolling out new international travel policies affecting Americans and noncitizens alike who want to fly into the U.S. The goal is to restore more normal air travel after 18 months of disruption caused by COVID-19.

37. China keeps virus at bay at high cost ahead of Olympics -

BEIJING (AP) — The Beizhong International Travel Agency in the eastern city of Tianjin has had only one customer since coronavirus outbreaks that began in July prompted Chinese leaders to renew city lockdowns and travel controls.

38. Pfizer says COVID-19 vaccine works in kids ages 5 to 11 -

Pfizer said Monday its COVID-19 vaccine works for children ages 5 to 11 and that it will seek U.S. authorization for this age group soon -- a key step toward beginning vaccinations for youngsters.

The vaccine made by Pfizer and its German partner BioNTech already is available for anyone 12 and older. But with kids now back in school and the extra-contagious delta variant causing a huge jump in pediatric infections, many parents are anxiously awaiting vaccinations for their younger children.

39. FDA panel is first key test for Biden COVID-19 booster plan -

WASHINGTON (AP) — The Biden administration's embattled plan to dispense COVID-19 booster shots to most Americans faced its first major hurdle Friday as a government advisory panel met to decide whether to endorse extra doses of the Pfizer vaccine.

40. FDA strikes neutral tone ahead of vaccine booster meeting -

WASHINGTON (AP) — Influential government advisers will debate Friday if there's enough proof that a booster dose of Pfizer's COVID-19 vaccine is safe and effective — the first step toward deciding which Americans need one and when.

41. UK recommends COVID-19 booster shots for over 50s -

LONDON (AP) — The U.K. said Tuesday it will offer a third dose of COVID-19 vaccine to everyone over age 50 and other vulnerable people after an expert panel said the boosters were needed to protect against waning immunity this winter.

42. Federal mandate takes vaccine decision off employers' hands -

Larger U.S. businesses now won't have to decide whether to require their employees to get vaccinated against COVID-19. Doing so is now federal policy.

President Joe Biden announced sweeping new orders Thursday that will require employers with more than 100 workers to mandate immunizations or offer weekly testing. The new rules could affect as many as 100 million Americans, although it's not clear how many of those people are currently unvaccinated.

43. Sweeping new vaccine mandates for 100 million Americans -

WASHINGTON (AP) — President Joe Biden on Thursday is announcing sweeping new federal vaccine requirements affecting as many as 100 million Americans in an all-out effort to increase COVID-19 vaccinations and curb the surging delta variant that is killing thousands each week and jeopardizing the nation's economic recovery.

44. US booster plan faces complications, some may miss Sept. 20 -

WASHINGTON (AP) — President Joe Biden's plans to start delivery of booster shots by Sept. 20 for most Americans who received the COVID-19 vaccines are facing new complications that could delay the availability of third doses for those who received the Moderna vaccine, administration officials said Friday.

45. EU, AstraZeneca reach deal to end vaccine delivery dispute -

BRUSSELS (AP) — The European Union and coronavirus vaccine-maker AstraZeneca said Friday that they have clinched an agreement to end a damaging legal battle over the slow pace of deliveries of the Anglo-Swedish company's shots.

46. France first big EU nation to start widespread booster jabs -

PARIS (AP) — France on Wednesday started administering booster shots of COVID-19 vaccine to people over 65 and those with underlying health conditions as the delta variant spreads in the country.

France is the first big EU country to introduce widespread booster shots, and several other European countries are expected to follow suit.

47. Japan suspends 1.63M doses of Moderna over contamination -

TOKYO (AP) — Japan suspended use of about 1.63 million doses of Moderna vaccine Thursday after contamination was found in unused vials, raising concern of a supply shortage as the country tries to accelerate vaccinations amid a COVID-19 surge.

48. Pfizer seeking FDA OK for COVID-19 vaccine booster dose -

Pfizer is seeking U.S. approval of a booster dose of its two-shot COVID-19 vaccine.

The drugmaker said Wednesday that it has started the application process for a third dose of its vaccine for everyone ages 16 and older. The company said it will complete the application with the Food and Drug Administration by the end of this week.

49. Pentagon: US troops must get their COVID-19 vaccines ASAP -

WASHINGTON (AP) — Military troops must immediately begin to get the COVID-19 vaccine, Defense Secretary Lloyd Austin said in a memo Wednesday, ordering service leaders to "impose ambitious timelines for implementation."

50. Stocks rise broadly; Pfizer gains after FDA approves vaccine -

Stocks closed higher on Wall Street Monday, allowing the S&P 500 to regain the ground it lost last week and bringing it just shy of another record high.

The benchmark index added 0.9%, driven by gains in a broad range of technology, financial and communication stocks.

51. Pentagon to mandate COVID-19 vaccine, as Pfizer is approved -

WASHINGTON (AP) — The Pentagon said Monday that it will require service members to receive the COVID-19 vaccine now that the Pfizer vaccine has received full approval.

Pentagon spokesman John Kirby said Defense Secretary Lloyd Austin is making good on his vow earlier this month to require the shots once the Food and Drug Administration approved the vaccine. He said guidance is being developed and a timeline will be provided in the coming days.

52. US regulators give full approval to Pfizer COVID-19 vaccine -

WASHINGTON (AP) — The U.S. gave full approval to Pfizer's COVID-19 vaccine Monday, potentially boosting public confidence in the shots and instantly opening the way for more universities, companies and local governments to make vaccinations mandatory.

53. Do I need a booster if I got the Johnson & Johnson vaccine? -

Do I need a booster if I got the Johnson & Johnson vaccine? Probably at some point, but health officials still are collecting the data needed to decide.

With boosters being planned in the U.S. as early as the fall for those who got the two-shot Pfizer and Moderna vaccines, recipients of the single-dose J&J jab might be wondering just how well their protection is holding up.

54. Record delta wave hits kids, raises fear as US schools open -

The day before he was supposed to start fourth grade, Francisco Rosales was admitted to a Dallas hospital with COVID-19, struggling to breathe, with dangerously low oxygen levels and an uncertain outcome.

55. US health officials call for booster shots against COVID-19 -

WASHINGTON (AP) — U.S. health officials Wednesday announced plans to dispense COVID-19 booster shots to all Americans to shore up their protection amid the surging delta variant and signs that the vaccines' effectiveness is falling.

56. EXPLAINER: What do we know about booster shots for COVID-19? -

U.S. health officials may soon recommend COVID-19 booster shots for fully vaccinated Americans. A look at what we know about boosters and how they could help fight the coronavirus:

WHY MIGHT WE NEED BOOSTERS?

57. DeSantis top donor invests in COVID drug governor promotes -

Florida Gov. Ron DeSantis — who has been criticized for opposing mask mandates and vaccine passports — is now touting a COVID-19 antibody treatment in which a top donor's company has invested millions of dollars.

58. Sources: US to recommend COVID vaccine boosters at 8 months -

WASHINGTON (AP) — U.S. health experts are expected to recommend COVID-19 booster shots for all Americans eight months after they get their second dose of the vaccine, to ensure longer-lasting protection as the delta variant spreads across the country.

59. Tennessee tops 1-month COVID hospitalization high in 2 weeks -

NASHVILLE (AP) — Tennessee's top health official said Monday that just halfway through August, the state has already shattered its single-month record for new COVID-19 hospitalizations.

Health Commissioner Lisa Piercey told reporters the surge in COVID-19 patients "really tips the scales" in hospitals even if there aren't as many people currently hospitalized with the virus as there were during the January peak.

60. US mulls COVID vaccine boosters for elderly as early as fall -

WASHINGTON (AP) — Warning of tough days ahead with surging COVID-19 infections, the director of the National Institutes of Health said Sunday the U.S. could decide in the next couple weeks whether to offer coronavirus booster shots to Americans this fall.

61. Extra COVID vaccine OK'd for those with weak immune systems -

WASHINGTON (AP) — U.S. regulators say transplant recipients and others with severely weakened immune systems can get an extra dose of the Pfizer or Moderna COVID-19 vaccines to better protect them as the delta variant continues to surge.

62. CDC urges COVID vaccines during pregnancy as delta surges -

The Centers for Disease Control and Prevention urged all pregnant women Wednesday to get the COVID-19 vaccine as hospitals in hot spots around the U.S. see disturbing numbers of unvaccinated mothers-to-be seriously ill with the virus.

63. Fauci hopeful COVID vaccines get full OK by FDA within weeks -

WILMINGTON, Del. (AP) — The U.S. government's top infectious disease expert, Dr. Anthony Fauci, said Sunday that he was hopeful the Food and Drug Administration will give full approval to the coronavirus vaccine by month's end and predicted the potential move will spur a wave of vaccine mandates in the private sector as well as schools and universities.

64. United Airlines will require US employees to be vaccinated -

United Airlines will require employees in the U.S. to be vaccinated against COVID-19 by late October, perhaps sooner, joining a growing number of big corporations that are responding to a surge in virus cases.

65. Moderna COVID-19 vaccine tallies more than $4B in Q2 sales -

Moderna's COVID-19 vaccine brought in more than $4 billion in second-quarter sales, helping to push the vaccine developer into a profit.

The company also said Thursday an analysis showed that its vaccine remains 93% effective as much as six months after the second dose.

66. Rapid virus spread through Indonesia taxes health workers -

JAKARTA, Indonesia (AP) — Irman Pahlepi is back at work in Jakarta's Dr. Suyoto public hospital, immediately resuming his duties treating COVID-19 patients after recovering from an infection himself — for the second time.

67. States race to use COVID-19 vaccines before they expire -

Hundreds of thousands of COVID-19 vaccine doses have been saved from the trash after U.S. regulators extended their expiration date for a second time, part of a nationwide effort to salvage expiring shots to battle the nation's summer surge in infections.

68. Moderna expanding kids vaccine study to better assess safety -

WASHINGTON (AP) — Moderna said Monday it plans to expand the size of its COVID-19 vaccine study in younger children to better detect rare side effects, such as a type of heart inflammation recently flagged by U.S. health authorities.

69. Vaccine deliveries rising as delta virus variant slams Asia -

JAKARTA, Indonesia (AP) — As many Asian countries battle their worst surge of COVID-19 infections, the slow flow of vaccine doses from around the world is finally picking up speed, giving hope that low inoculation rates can increase and help blunt the effect of the rapidly spreading delta variant.

70. Immunized but banned: EU says not all COVID vaccines equal -

LONDON (AP) — After Dr. Ifeanyi Nsofor and his wife received two doses of AstraZeneca's coronavirus vaccine in Nigeria, they assumed they would be free to travel this summer to a European destination of their choice. They were wrong.

71. US officials flag "small" reaction risk with J&J vaccine -

WASHINGTON (AP) — Johnson & Johnson's COVID-19 vaccine may pose a "small possible risk" of a rare but potentially dangerous neurological reaction, U.S. health officials said Monday.

The Centers for Disease Control and Prevention said in a statement it has received reports of 100 people who got the shot developing Guillain-Barré syndrome, an immune system disorder that can cause muscle weakness and occasionally paralysis.

72. Pfizer to discuss COVID-19 vaccine booster with US officials -

WASHINGTON (AP) — Pfizer says it plans to meet with top U.S. health officials Monday to discuss the drugmaker's request for federal authorization of a third dose of its COVID-19 vaccine as President Joe Biden's chief medical adviser acknowledged that "it is entirely conceivable, maybe likely" that booster shots will be needed.

73. Biden misses vaccine-sharing goal, cites local hurdles -

WASHINGTON (AP) — President Joe Biden came up well short on his goal of delivering 80 million doses of coronavirus vaccine to the rest of the world by the end of June as a host of logistical and regulatory hurdles slowed the pace of U.S. vaccine diplomacy.

74. Is Japan's remarkable vaccine drive in time for Olympics? -

TOKYO (AP) — After months of frustration and delay, Japan has hit the remarkable benchmark of 1 million vaccines a day. But with the Olympics set to start in less than a month, and only a small portion of the country vaccinated, a question lingers: Is it enough?

75. A look at travel rules in popular European destinations -

Europe is opening up to Americans and other visitors after more than a year of COVID-induced restrictions. But travelers will need patience to figure out who's allowed into which country, how and when.

76. Biden outlines vaccine plan, set to miss global-sharing goal -

WASHINGTON (AP) — President Joe Biden is expected to fall short of his commitment to shipping 80 million COVID-19 vaccine doses abroad by the end of June because of regulatory and other hurdles, officials said as they announced new plans Monday for sharing the shots globally.

77. Novavax: Large study finds COVID-19 shot about 90% effective -

Vaccine maker Novavax said Monday its COVID-19 shot was highly effective against the disease and also protected against variants in a large study in the U.S. and Mexico, potentially offering the world yet another weapon against the virus at a time when developing countries are desperate for doses.

78. US vaccine surplus grows by the day as expiration dates loom -

In Tennessee and North Carolina, demand for the COVID-19 vaccine has slowed down so much that they have given millions of doses back to the federal government, even though less than half of their total populations are vaccinated.

79. China's children may be next in line for COVID-19 vaccines -

TAIPEI, Taiwan (AP) — If China is to meet its tentative goal of vaccinating 80% of its population against the coronavirus by the end of the year, tens of millions of children may have to start rolling up their sleeves.

80. US extends expiration dates for J&J COVID vaccine by 6 weeks -

WASHINGTON (AP) — Johnson & Johnson said Thursday that U.S. regulators extended the expiration date on millions of doses of its COVID-19 vaccine by six weeks.

The company said a Food and Drug Administration review concluded the shots remain safe and effective for at least 4 1/2 months. In February, the FDA originally authorized J&J's vaccine for up to three months when stored at normal refrigeration levels.

81. France is back: Borders reopen to American tourists, others -

PARIS (AP) — After "a very bad year," Paris tour operator Marc Vernhet sees a ray of light with the promised return of tourists from the United States and elsewhere who are welcome in France as of Wednesday if they have been vaccinated against the coronavirus.

82. US stocks claw back much of an early loss, finish mixed -

Stocks gave up some of their recent gains Monday, though the selling eased toward the end of the day, leaving the major indexes mixed.

The S&P 500 slipped less than 0.1% after having been down 0.3% in the early going. The benchmark index, which is coming off two straight weekly gains, is within 0.2% of the all-time high it reached a month ago.

83. US will boost global vaccine-sharing, Biden announces -

WASHINGTON (AP) — President Joe Biden announced Thursday the U.S. will donate 75% of its unused COVID-19 vaccines to the U.N.-backed COVAX global vaccine sharing program, acting as more Americans have been vaccinated and global inequities have become more glaring.

84. Conquer and prevail -

Dr. William Schaffner still remembers the note left on his desk decades ago. In scrawled black marker it said: “I got it! B”

B was Dr. Barney Graham, a young internist at Vanderbilt University Medical Center. Graham had arrived in Nashville in 1979, fresh from the University of Kansas School of Medicine. These days, he guides a team of scientists at the National Institutes of Health that, along with others with Vanderbilt ties across the country, have helped the world understand and fight COVID-19.

85. Moderna seeks full FDA approval for its vaccine -

CAMBRIDGE, Mass. (AP) - American pharmaceutical company Moderna says it has begun the process to win full U.S. regulatory approval for the use of its COVID-19 vaccine in adults.

Moderna announced Tuesday it has begun a "rolling submission" to the Food and Drug Administration of data from its studies of the two-dose vaccine.

86. Who benefits? US debates fairest way to share spare vaccine -

WASHINGTON (AP) — In April, the Biden administration announced plans to share millions of COVID-19 vaccine doses with the world by the end of June. Five weeks later, nations around the globe are still waiting — with growing impatience — to learn where the vaccines will go and how they will be distributed.

87. Moderna says its vaccine works in children as young as 12 -

Moderna said Tuesday its COVID-19 vaccine strongly protects kids as young as 12, a step that could put the shot on track to become the second option for that age group in the U.S.

With global vaccine supplies still tight, much of the world is struggling to vaccinate adults in the quest to end the pandemic. But earlier this month, the U.S. and Canada authorized another vaccine — the shot made by Pfizer and BioNTech — to be used starting at age 12.

88. Japan opens mass vaccine centers 2 months before Olympics -

TOKYO (AP) — Japan mobilized military doctors and nurses to give shots to elderly people in Tokyo and Osaka on Monday as the government desperately tries to accelerate its vaccination rollout and curb coronavirus infections just two months before hosting the Olympics.

89. China says it's providing vaccines to almost 40 African states -

BEIJING (AP) — China said Thursday it is providing COVID-19 vaccines to nearly 40 African countries, describing its actions as purely altruistic in an apparent intensification of what has been described as "vaccine diplomacy."

90. EU takes big step toward relaxing travel for vaccinated -

BRUSSELS (AP) — The European Union took a step toward relaxing travel rules for tourists from outside the 27-nation bloc Wednesday when EU ambassadors agreed on measures to allow in fully vaccinated visitors.

91. Biden to boost world vaccine sharing commitment to 80M doses -

WASHINGTON (AP) — President Joe Biden will announce Monday that the U.S. will share an additional 20 million doses of COVID-19 vaccines with the world in the coming six weeks, the White House said.

92. Poll: Most in US who remain unvaccinated need convincing -

Fewer Americans are reluctant to get a COVID-19 vaccine than just a few months ago, but questions about side effects and how the shots were tested still hold some back, according to a new poll that highlights the challenges at a pivotal moment in the U.S. vaccination campaign.

93. Vaccine maker BioNTech says no need to waive patents -

BERLIN (AP) — The head of German pharmaceutical company BioNTech said Monday that there is no need to waive patents on coronavirus vaccines because manufacturers will be able to produce enough shots to supply the world over the coming year.

94. Publix offers walk-in COVID vaccines in Tennessee, 6 other states -

FORT LAUDERDALE, Fla. (AP) — Publix pharmacies are now accepting walk-ins for the COVID-19 vaccine at all of their locations across seven states.

The Lakeland-based supermarket chain said on its website that customers have the choice of the two-dose Moderna vaccine, or the one-dose Johnson & Johnson vaccine, subject to availability.

95. COVID-vaccine maker BioNTech reports $1.37B profit in Q1 -

BERLIN (AP) — German pharmaceutical company BioNTech reported a net profit of 1.13 billion euros ($1.37 billion) in the first quarter of this year on the back of strong revenues from its coronavirus vaccine.

96. UK to offer under-40s alternative to AstraZeneca shot -

LONDON (AP) — People under 40 in Britain will not be given the Oxford-AstraZeneca coronavirus vaccine if another shot is available because of a link to extremely rare blood clots, the government said Friday. It said the change would not affect the goal of giving all U.K. adults at least one vaccine dose by July.

97. US stocks close higher as banks, technology lead broad rally -

A choppy day of trading on Wall Street ended Thursday with stocks broadly higher and another all-time high for the Dow Jones Industrial Average.

Banks and technology companies led a late-afternoon turnaround that pushed the S&P 500 to a 0.8% gain, reversing the benchmark index's losses for the week. Gains in most Dow companies, including Goldman Sachs, IBM and Cisco Systems, nudged the blue chip index to a new high for the second straight day.

98. FDA expected to OK Pfizer vaccine for teens within week -

WASHINGTON (AP) — The U.S. Food and Drug Administration is expected to authorize Pfizer's COVID-19 vaccine for youngsters ages 12 to 15 by next week, according to a federal official and a person familiar with the process, setting up shots for many before the beginning of the next school year.

99. Attention travelers! EU proposes reopening external borders -

BRUSSELS (AP) — In an announcement sure to be welcomed by travelers worldwide, EU officials on Monday proposed easing restrictions on visiting the 27-nation bloc as vaccination campaigns across the continent gather speed.

100. UN program inks Moderna deal on 500M doses, starting in Q4 -

GENEVA (AP) — U.S. biotech company Moderna will provide up to 500 million doses for the U.N.-backed program to ship coronavirus vaccines to needy people in low- and middle-income countries, but shipments won't begin until the fourth quarter, the company and program leaders said Monday.